<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0057">
 <label>57</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Musharrafieh</surname>
    <given-names>R</given-names>
   </string-name>, 
   <string-name>
    <surname>Ma</surname>
    <given-names>C</given-names>
   </string-name>, 
   <string-name>
    <surname>Zhang</surname>
    <given-names>J</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Validating Enterovirus D68-2A(pro) as an antiviral drug target and the discovery of Telaprevir as a potent D68-2A(pro) inhibitor</article-title>. 
  <source>J Virol</source>. 
  <year>2019</year> Mar 21; 93(7):e02221â€“18.
 </mixed-citation>
</ref>
